Cardiac Ablation Solutions
HRS 2024 Programs
HRS 2024 is just around the corner and Cardiac Ablation Solutions will have a number of programs and events available throughout the congress. Be the first to hear the results of the SPHERE Per-AF trial at our late breaker or learn more about our pulsed field ablation (PFA) technologies during our lunch symposium and rhythm theater.
SPHERE Per-AF Trial
HRS 2024 Late-Breaking Clinical Trial
A Randomized Controlled Trial of a Lattice-Tip Mapping and Ablation System with Radiofrequency and Pulsed Field Energy for Treating Persistent Atrial Fibrillation
The only randomized controlled trial comparing the Affera™ Mapping and Ablation System with Sphere-9™ Catheter to the CARTO®* Navigation & Mapping System with Thermocool SmartTouch®* SF Catheter for the treatment of patients with persistent atrial fibrillation.
Don't miss the presentation of the SPHERE Per-AF data at HRS 2024, presented by Principal Investigator Elad Anter, M.D.
Friday, May 17, 2024
4:00-4:10 p.m. E.T.
Ballroom East West - BCEC
Caution: Investigational device not available for sale in the U.S.
Get the data first
Sign up below and be among the first to get the data upon publication. We will share the results with you via email as soon as they are published.
Engineering Lab
Visit the Engineering Lab in the Medtronic booth to see the latest technologies and provide feedback on innovations, including the Affera Mapping and Ablation System from Cardiac Ablation Solutions. Receive a high-level overview of the Affera system, the all-in-one Sphere-9 Catheter, and the Prism-1 Mapping Software.
No appointment or registration is needed. A signed NDA (non-disclosure agreement) is required to enter the lab.
Caution: Investigational device not available for sale in the U.S.
Lunch Symposium
Innovations across multiple energy sources: Clinical experience with single shot PulseSelect™ PFA and Affera™ Sphere-9™ wide area focal PF/RF catheters. A look at the advantages of the latest Arctic Front™ Cryoablation advancements in clinical practice.
Friday, May 17, 2024
12:00-2:00 p.m. E.T. (check-in from 12:00-12:30)
Location: Boston Convention Center, Room 210bc
Faculty:
- Arash Aryana, M.D.
- Jonathan Silver, M.D.
- Andreas Metzner, M.D.
Moderated by Khaldoun Tarakji, M.D.
Rhythm Theater
Single Shot PFA technologies to treat Persistent and Paroxysmal AF: PulseSelect™ and Affera™ Sphere-360™
Join us for real-world clinical experience with the PulseSelect PFA system. Learn about a Zero Fluoro & Zero Exchange workflow experience with PulseSelect and hear about first-in-human clinical experience with the novel Affera Sphere-360 PFA catheter.
Saturday, May 18, 2024
3:30-4:30 p.m. E.T.
Location: Rhythm Theater 1
Faculty:
- Oussama Wazni, M.D.
- Devi Nair, M.D.
- Vivek Reddy, M.D.
Caution: Sphere-360 is an investigational device not available for sale in any geography.
Caution: Sphere-9 is an investigational device not available for sale in the U.S.
PulseSelect: Risks may include serious complications and injuries to cardiac and other body structures. The PulseSelect™ Pulsed Field Ablation system should only be used by or under the supervision of a physician that performs pulsed field ablation procedures.
These programs are not part of Heart Rhythm 2024 as planned by the Heart Rhythm Program Committee. These events are neither sponsored nor endorsed by the Heart Rhythm Society. These events do not qualify for accredited continuing education (ACE) credit.
Meet the Experts
Stop by the Cardiac Ablation Solutions section of the Medtronic booth to talk to the experts and get your questions answered.
Saturday, May 18 2024
9:00–10:00 a.m. E.T.
SPHERE Per-AF trial results
Elad Anter, M.D.
Principal investigator
Shamir Medical Center
11:00 a.m.–12:00 p.m. E.T.
PulseSelect and FlexCath Cross Case Experience
Ilyas Colombowala, M.D.
Houston Methodist
Don't miss a thing at HRS
Sign up to receive a calendar invitation and reminders for each of the programs. Select one or more of the programs and we'll send you a calendar invitation for each one.
Choose one or more options:*
© 2024 Medtronic. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. ®*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. CAS_HRS_HCP_May2024